IRON AMINOS IGF-1 LR3 1MG
Research-grade insulin-like growth factor analog prepared for consistency and clear documentation in professional lab workflows.
Key Features
-
1mg IGF-1 LR3 per vial (lyophilized powder)
-
≥99% purity for reproducible results
-
Sterile, sealed glass vial with tamper-evident flip cap
-
Lot and batch labeling for traceability
-
Signature Iron Aminos red-honeycomb label for quick identification
-
Diluent not included
Specifications
-
Compound: IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1)
-
Design: 13-amino-acid N-terminal extension with Arg substitution at position 3 to reduce IGF-binding protein affinity and prolong activity in research models
-
Form / appearance: Lyophilized powder, white to off-white
-
Amount: 1mg per vial
-
Purity: ≥99%
-
Storage (lyophilized): Cool, dry, away from light
-
Storage (after reconstitution): Refrigerate and use promptly per internal SOP
What’s Included
-
1 × IGF-1 LR3 1mg vial (no diluent)
Handling
Use an appropriate sterile diluent and aseptic technique. Follow your lab’s SOPs for reconstitution, aliquoting, labeling, and disposal.
Research Snapshot
-
IGF-1 receptor agonism activates PI3K/Akt and MAPK signaling that drives cell growth, protein synthesis, and survival in vitro.
-
The LR3 modification reduces binding to IGFBPs, yielding greater bioavailability and longer activity compared with native IGF-1 in preclinical models.
-
Reported research outcomes include myoblast differentiation, satellite cell activation, and enhanced nutrient uptake in muscle cell systems, along with exploratory work in neuroprotection and cartilage models.
-
Class-typical study observations can include hypoglycemia, edema, and jaw/limb discomfort in vivo models when exposure is high. Protocols often titrate carefully and monitor glucose.
Compliance
For research use only. Not for human consumption.
Not a drug, food, or cosmetic and not intended to diagnose, treat, cure, or prevent any disease.
